Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 9;13(1):11.
doi: 10.1186/1472-6815-13-11.

Posterior laryngitis: a disease with different aetiologies affecting health-related quality of life: a prospective case-control study

Affiliations

Posterior laryngitis: a disease with different aetiologies affecting health-related quality of life: a prospective case-control study

Hillevi Pendleton et al. BMC Ear Nose Throat Disord. .

Abstract

Background: Laryngo-pharyngeal reflux (LPR) is assumed to be the most common cause of posterior laryngitis (PL). Since LPR is found in healthy subjects, and PL patients are not improved by acid-reducing therapy, other aetiologies to PL must be considered. The aims of this study in PL were to investigate the prevalence of acid reflux in the proximal oesophagus and functional gastrointestinal symptoms, to analyse motilin levels in plasma, and to assess health-related quality of life (HRQOL) before and after treatment.

Methods: Forty-six patients (26 women), with verified PL, median age 55 (IQR 41-68) years, were referred to oesophago-gastro-duodenoscopy and 24-h pH monitoring. Plasma motilin was analysed. The 36-item Short-Form questionnaire was completed at inclusion and at follow-up after 43±14 months, when also the Visual Analogue Scale for Irritable Bowel Syndrome was completed. Values were compared to controls. Treatment and relief of symptoms were noted from medical records.

Results: Thirty-four percent had proximal acid reflux and 40% showed signs of distal reflux. Ninety-four percent received acid-reducing treatment, with total relief of symptoms in 17%. Patients with reflux symptoms had lower plasma motilin levels compared to patients without reflux symptoms (p = 0.021). The HRQOL was impaired at inclusion, but improved over time. Patients, especially men, had more functional gastrointestinal symptoms than controls.

Conclusions: This study indicates that a minority of patients with PL has LPR and is cured by acid-reducing therapy. Disturbed plasma motilin levels and presence of functional gastrointestinal symptoms are found in PL. The impaired HRQOL improves over time.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow-chart illustrating the selection process and the number of procedures among the included patients.
Figure 2
Figure 2
Analysis of the SF-36 questionnaire at inclusion in the population of men and women with posterior laryngitis (PL) and the general Swedish population. Gender- and age-matched values are presented as mean values. PF = physical functioning, RP = role-physical, BP = bodily pain, GH = general health, VT = vitality, SF = social functioning, RE = role-emotional, ME = mental health. One-sample t-test. P ≤ 0.050 was considered statistically significant.
Figure 3
Figure 3
Analysis of the SF-36 questionnaire at follow-up in the population of men and women with posterior laryngitis (PL) and the general Swedish population. Gender- and age-matched values are presented as mean values. PF = physical functioning, RP = role-physical, BP = bodily pain, GH = general health, VT = vitality, SF = social functioning, RE = role-emotional, ME = mental health. One-sample t-test. P ≤ 0.050 was considered statistically significant.
Figure 4
Figure 4
Analysis of the VAS-IBS questionnaire, expressed as median z-scores, for the PL group and the controls at follow-up. AP = abdominal pain, D = diarrhoea, C = constipation, BF = bloating and flatulence, VN = vomiting and nausea, PW = perception of mental well-being, IDL = intestinal symptoms effect on daily life. Mann–Whitney U-test. P ≤ 0.050 was considered statistically significant. * = Significant difference to controls-women, ** = Significant difference to controls-men.

Similar articles

References

    1. Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg. 2000;123(4):385–388. doi: 10.1067/mhn.2000.109935. - DOI - PubMed
    1. Hopkins C, Yousaf U, Pedersen M. Acid reflux treatment for hoarsness. Cochrane Database Syst Rev. 2006;25(1):CD005054. - PubMed
    1. Pearson JP, Parikh S, Orlando RC, Johnston N, Allen J, Tinling SP, Belafsky P, Arevalo LF, Sharma N, Castell DO. et al.Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21–23 April 2010. Aliment Pharm Ther. 2011;33(Suppl 1):1–71. - PubMed
    1. Watson MG. Review article:laryngopharyngeal reflux-the ear, nose and throat patient. Aliment Pharm Ther. 2011;33(Suppl 1):53–57.
    1. Bove MJ, Rosen C. Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2006;14(3):116–123. doi: 10.1097/01.moo.0000193177.62074.fd. - DOI - PubMed

LinkOut - more resources